SAN FRANCISCO, March 03, 2016 -- APT Systems, Inc. (OTC Pink:APTY), a fully reporting company in the fintech software sector, announced today that it had finalized its selection for a potential FOREX trading system acquisition and entered into agreements for additional testing.
As part of their due diligence, the Company has engaged one of the developers, Chris Dodigovich, to run the software that was launched 5 years ago, and trade using its cash to establish how the indicators currently perform. Employing cash in the testing process is an important part of our development strategy and any profits generated go back into our product development budgets.
“It has been an exciting few months with APTY being fully quoted on the OTC and we now have the ability to move forward with our software development plans,” says Glenda Dowie, President and CEO.
The Company has plans to integrate a FOREX trading component into its Proprietary Trading system. This acquisition, when complete will diversify our revenue potential by increasing the range of products we can offer on handheld devices. We are comfortable in the equities market technology and welcome this immediate boost in the FOREX arena. We also look forward to announcing the testing results in months to come.
About APT Systems, Inc.
APT is an acronym for Applied Proprietary Trading. The Management of APT Systems, Inc. works to deliver stock trading tools with a focus on handheld devices while also strategically acquiring other compatible financial businesses which demonstrate strong growth potential.
Disclaimer - Forward Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements; projected events in this press release may not occur due to unforeseen circumstances, various factors, and other risks identified in a company's annual report on Form 10-K and other filings made by such company.
Contact www.aptsystemsinc.com Investor Relations at Teso Communications 1-888-648-0488 or write to [email protected] @APTYsys - now you can the company on Twitter


Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



